Tianjin Pharmaceutical Da Ren Tang Group unit Tianjin Pharmaceutical Group Finance, a non-bank financial institution, plans to increase its registered capital from 500 million yuan to 1 billion yuan to meet regulatory requirements, according to a Friday filing on the Singapore Exchange.
This follows Tianjin Pharmaceutical Holdings (TPH) acquiring an additional 15% stake in Tianjin Pharmaceutical Group Finance, raising its ownership to 30%.
To comply with financial regulations, Tianjin Pharmaceutical Group Finance's shareholders, including Tianjin Pharmaceutical Holdings, the company, Tianjin Yaoye, and Tianjin Jin Yi Investment, have agreed to a proportional capital increase.
Tianjin Pharmaceutical Group Finance will contribute 150 million yuan, about 2.3% of its latest audited net tangible assets of 6.53 billion yuan.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。